EQS-News: PL BioScience Announces Conferences Attendance

PL BioScience Announces Conferences Attendance

Aachen, Germany, September 30, 2025 – PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced its participation in six life sciences conferences this fall.

Meet our management team and marketing colleagues at one of the upcoming conferences:

Festival of BiologicsSeptember 30 – October 2 in Basel, SwitzerlandAnna Kolkmann (Sales Manager) and Maria Noronha (Marketing Specialist) will be presentBooth: 501CScheduling meetings is possible through the Terrapinn Event App

BioJapanOctober 8 – 10 in Yokohama, JapanJungsoo Park (VP Marketing & Sales) and Kana Miyakubi (Sales Account Manager) will be presentBooth: B-68 at the EU-Japan Centre for Industrial Cooperation Pavilion

Innovative Therapies Days 2025October 9 – 10 in Besançon, FranceSilver Sponsor of the conferenceCécilia Mesa (Sales Manager) will be present and exhibit a posterBooth: 6Scheduling meetings is possible through the B2Match platform

CPHI Frankfurt 2025October 28 – 30 in Frankfurt, GermanyHatim Hemeda (CEO & Co-Founder), Christian Wilkes (CFO & Co-Founder) and Jungsoo Park will be presentBooth: 4S115Scheduling meetings and contacting are possible through the CPHI Event Planner App

BIO-EUROPE 2025November 3 – 5 in Vienna, AustriaHatim Hemeda and Christian Wilkes will be presentScheduling meetings through the partneringONE system

Cell 2025November 11 – 12 in London, United KingdomNetwork & Programme SponsorsSilke Isenhardt (Field Application Scientist) and Maria Noronha (Marketing Specialist) will be present and exhibit a posterBooth: 54Contact will be possible through the event app from November

About PL BioScience:

PL BioScience GmbH, a life science company located in Aachen, Germany, specializes in the production and development of Human Platelet Lysate (HPL). The company has pioneered proprietary technology to produce fully artificial HPL, allowing for a fully lab-made, scalable supply of HPL. PL BioScience currently offers a comprehensive portfolio of donor-derived, natural HPL products tailored for a range of applications – the ELAREMTM platform. From academic and preclinical research to cell therapy and biopharmaceutical manufacturing, ELAREM™ ensures seamless translations of regenerative medicine breakthroughs – from the lab to patients in need. PL BioScience is the only company worldwide holding a patent for the gamma-irradiation of HPL, covering the manufacturing process for ELAREM™ Ultimate-FD PLUS.

For more information on PL BioScience and the ELAREM™ platform, visit: www.pl-bioscience.com

Contact:Dr. Hatim Hemeda, CEOPL BioScience GmbH+49(0)24195719-100info@pl-bioscience.com

Media contact:MC Services AGRaimund Gabriel, Dr. Regina Lutz+49 (0)89 210 228 0

U.S.: Catherine Featherston+1-203-444-4393E-Mail: plbioscience@mc-services.eu